ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $165,554 | -51.0% | 6,100 | -44.5% | 0.00% | -50.0% |
| Q2 2023 | $338,140 | +218054.8% | 11,000 | +155.8% | 0.00% | +100.0% |
| Q1 2023 | $155 | -97.5% | 4,300 | -97.2% | 0.00% | -97.9% |
| Q4 2022 | $6,079 | -98.5% | 153,819 | +1414.1% | 0.05% | +1100.0% |
| Q3 2022 | $415,000 | +12.2% | 10,159 | +9.9% | 0.00% | +33.3% |
| Q4 2021 | $370,000 | -7.3% | 9,244 | -16.2% | 0.00% | +50.0% |
| Q3 2021 | $399,000 | – | 11,027 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |